NCT03141476View on ClinicalTrials.gov

Adequacy of Perioperative Cefuroxime Dosage According to the BMI

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

November 12, 2017

Study Completion Date

December 12, 2017

Conditions
Obesity; Drug
Interventions
DRUG

Cefuroxime 1,5g

Patients with BMI of \<30kg/m\*m: 1,5 g Cefuroxime

DRUG

Cefuroxime 3g

Patients with BMI of 30-50kg/m\*m: 3g Cefuroxime

DRUG

Cefuroxime 4,5g

Patients with BMI of \>50kg/m\*m: 4,5 g Cefuroxime

Trial Locations (1)

20246

University Hospital Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT03141476 - Adequacy of Perioperative Cefuroxime Dosage According to the BMI | Biotech Hunter | Biotech Hunter